Title:
ANTI-CGRP ANTIBODY AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/239014
Kind Code:
A1
Abstract:
Disclosed are a novel antibody, in particular an antibody or an antigen binding fragment thereof which binds to the CGRP antigen, and a preparation method, a composition and an application. The antibody has strong binding capability to the CGRP antigen, low immunogenicity and a long in vivo half-life, and may be used for treating and/or preventing CGRP-related diseases, such as headaches, or for immunological CGRP antigen detection.
More Like This:
Inventors:
SONG DEYONG (CN)
LIU XIU (CN)
DONG CHUANGCHUANG (CN)
LIU XIU (CN)
DONG CHUANGCHUANG (CN)
Application Number:
PCT/CN2020/092892
Publication Date:
December 03, 2020
Filing Date:
May 28, 2020
Export Citation:
Assignee:
SHANDONG BOAN BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P25/06; C12N15/63
Domestic Patent References:
WO2018081648A2 | 2018-05-03 | |||
WO2017132062A1 | 2017-08-03 | |||
WO2010075238A1 | 2010-07-01 | |||
WO2009109908A1 | 2009-09-11 | |||
WO2015143409A1 | 2015-09-24 |
Foreign References:
EP3363461A1 | 2018-08-22 |
Download PDF: